Back to Search
RAHEELA ASHFAQ, MD FACP
MD FACP
Cytopathology Physician
NPI: 1912976457Individual
Specialties, Licenses & Credentials
Research & Publications (20)
p53 expression in patients with advanced urothelial cancer of the urinary bladder.
PMID 19659466·BJU Int·2010
4-observational
Saline-infusion sonography endometrial sampling compared with endometrial biopsy in diagnosing endometrial pathology.
PMID 19305334·Obstet Gynecol·2009
8-other
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
PMID 19141773·J Natl Cancer Inst·2009
4-observational
Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder.
PMID 19596509·Eur Urol·2009
8-other
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
PMID 18585843·Eur Urol·2009
8-other
p53 predictive value for pT1-2 N0 disease at radical cystectomy.
PMID 19616250·J Urol·2009
4-observational
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
PMID 19447418·J Urol·2009
8-other
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
PMID 18008359·Cancer·2008
8-other
Differential roles of telomere attrition in type I and II endometrial carcinogenesis.
PMID 18599611·Am J Pathol·2008
7-preclinical
Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.
PMID 18836286·Cancer Biol Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6655 N MACARTHUR BLVD
IRVING, TX 75039 - Phone
- (214) 277-8700
Quick Facts
- NPI
- 1912976457
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile